• Give Patients the Tools to Treat Obesity and Protect Liver Health
  • Your Story Can Change the Future of Liver Health
  • Give Patients the Tools to Treat Obesity and Protect Liver Health
  • Your Story Can Change the Future of Liver Health
1
2
Your Story Can Change the Future of Liver Health
Your voice has the power to move Congress and CMS to act. Lawmakers hear from lobbyists every day — but it’s your personal story that makes them listen. When you share how liver disease has touched your life, you put a human face on urgent policy decisions and remind them...
Give Patients the Tools to Treat Obesity and Protect Liver Health
Update as of July 7, 2025: The Treat and Reduce Obesity Act (TROA) has now been officially introduced in both the House and Senate. Thank you to the bipartisan group of Representatives and Senators leading the way on TROA and fighting for equitable access to obesity care...
Reintroduction of The Living Donor Protection Act
Every day, living organ donors save lives but too often, they face discrimination from insurance companies when they step up to give the gift of life.The Living Donor Protection Act (LDPA), H.R. 4583,  would break down barriers to donation by:- Prohibiting life,...
Introduction of Living Donor Family and Medical Leave Act Protection Act
Every day, living organ donors save lives but too often, they face a lack job protections when they step up to give the gift of life.The Living Donor FMLA Protection Act, H.R.4582, would break down barriers to donation by:- Guaranteeing that living organ donation...
Protect the Hepatitis B Birth Dose for Newborns
The CDC’s Advisory Committee on Immunization Practices (ACIP) is reconsidering one of the most critical tools in our public health arsenal: the universal hepatitis B birth dose. Despite over 30 years of success, some ACIP members are now questioning whether newborns should...
ACT NOW: Expand Access to Anti-Obesity Medications for Liver Health
Obesity is one of the leading drivers of steatotic liver disease, especially metabolic dysfunction-associated steatotic liver disease (MASLD)—a serious and growing condition now affecting more than 80 million adults across the U.S. When left untreated, MASLD can lead to...
VoterVoice
Cookie Preferences Privacy Policy